 |
|
New Targeted Therapy for Non-Small Cell Lung Cancer
Eun Ki Chung, Seung Hyun Yong, Eun Hye Lee, Eun Young Kim, Yoon Soo Chang, Sang Hoon Lee
Tuberc Respir Dis. 2023;86(1):1-13. Published online 2022 Oct 5 DOI: https://doi.org/10.4046/trd.2022.0066
|
|
Citations to this article as recorded by
 Mitochondrial targeting derivatives of honokiol enhanced selective antitumor activity in NCI-H446 cells and decreased in vivo toxicity in Caenorhabditis elegans
Huicong Miao, Wenbo Cui, Tao Zhang, Yue Zhang, Jiaozhen Zhang, Hongxiang Lou, Peihong Fan
European Journal of Medicinal Chemistry.2024; 264: 115996. CrossRef Label-Free Ratiometric Homogeneous Electrochemical Strategy Based on Exonuclease III-Aided Signal Amplification for Facile and Rapid Detection of miR-378
Bingyuan Fan, Qian Wang, Shan Wang, Yahui Gao, Yan Liang, Jinru Pan, Xinrui Fu, Li Li, Wei Meng
International Journal of Analytical Chemistry.2024; 2024: 1. CrossRef Dual-Temperature/pH-Sensitive Hydrogels with Excellent Strength and Toughness Crosslinked Using Three Crosslinking Methods
Jiaqi Wang, Wanying Yang, Yutong Li, Xuerong Ma, Yuxin Xie, Guangyan Zhou, Shouxin Liu
Gels.2024; 10(7): 480. CrossRef Novel sulfonamides unveiled as potent anti-lung cancer agents via tumor pyruvate kinase M2 activation
Rudradip Das, Deep Rohan Chatterjee, Saumya Kapoor, Het Vyas, Amit Shard
RSC Medicinal Chemistry.2024; 15(9): 3070. CrossRef New targeted therapies for non-small cell lung cancer
Eun Hye Lee, Se Hyun Kwak, Chi Young Kim, Hye Ran Gwon, Eun Young Kim, Yoon Soo Chang
Journal of the Korean Medical Association.2023; 66(3): 180. CrossRef Case Report: A case of ultra-late recurrence of KIF13A-RET fusion non-small cell lung cancer response to selpercatinib
Ha-Young Park, Joo-Heon Park, Myung-Geun Shin, Seung Jung Han, Yong-Sok Ji, Hyung-Joo Oh, Young-Chul Kim, Taebum Lee, Yoo-Duk Choi, In-Jae Oh
Frontiers in Oncology.2023;[Epub] CrossRef
|